Montelukast: Regulator reviewing asthma drug over concerns about mental health effects

BMJ. 2024 Mar 5:384:q563. doi: 10.1136/bmj.q563.
No abstract available

MeSH terms

  • Acetates / adverse effects
  • Cyclopropanes
  • Humans
  • Mental Health*
  • Quinolines* / adverse effects
  • Sulfides*

Substances

  • montelukast
  • Acetates
  • Cyclopropanes
  • Quinolines
  • Sulfides